An observational, prospective cohort study to evaluate the safety and efficacy of Remsima in patients with Crohn's disease (CD) and Ulcerative Colitis (UC)

First published 10/06/2015

Last updated 15/02/2019

EU PAS number:

EUPAS9917

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

CT-P13 4 3 IBD registry protocol_EU-specific_Ver 2.1_Final_03Jun15 Synopsis for PASS_clean

English (31.03 KB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

An observational, prospective cohort study to evaluate the safety and efficacy of Remsima in patients with Crohn's disease (CD) and Ulcerative Colitis (UC)

Secondary tabs

Share this page